Thomas R. Carper bought Nutrien Ltd (NYSE: NTR)
Thomas R. Carper (D-DE), a U.S. Senator, has disclosed 1 trade in Nutrien Ltd (NTR) since 2024, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Thomas R. Carper bought $1,001 - $15,000 of Nutrien Ltd (NYSE: NTR) on March 28, 2024. Since that trade, NTR is up +41.00% against the S&P 500 up +45.25%, an outperformance of -4.25%.
Data updated
Thomas R. Carper's NTR trades vs the price
NTR is up +41.00% since Thomas R. Carper bought on March 28, 2024, versus +45.25% for the S&P 500.
Performance since this trade
All Thomas R. Carper NTR trades
Thomas R. Carper & NTR trading FAQ
Is it legal for Thomas R. Carper to trade Nutrien Ltd (NTR) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Nutrien Ltd (NTR), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Thomas R. Carper buy NTR?
Thomas R. Carper disclosed a purchase of $1,001 - $15,000 of Nutrien Ltd (NTR) on March 28, 2024, according to public STOCK Act filings.
How has NTR performed since Thomas R. Carper's trade?
Since Thomas R. Carper bought NTR on March 28, 2024, the stock is up +41.00%, versus +45.25% for the S&P 500 over the same period, an outperformance of -4.25%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NTR trades?
Quantellect tracks every disclosed congressional trade in Nutrien Ltd (NTR) on the Nutrien Ltd congressional trading page, which aggregates filings across all members of Congress.
Thomas R. Carper's NTR tradesAll congressional filings for Nutrien LtdThomas R. Carper's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.